v3.25.1
Consolidated Statements of Operations - USD ($)
8 Months Ended 12 Months Ended
Dec. 31, 2024
Apr. 30, 2024
Apr. 30, 2023
Income Statement [Abstract]      
Revenues $ 4,850,304 $ 17,836,382 $ 4,620,834
Cost of goods sold 6,206,378 14,155,836 5,455,145
Gross (loss) profit (1,356,074) 3,680,546 (834,311)
Operating Expenses      
Research and development 6,610,980 6,266,129 5,860,189
Sales and marketing 6,321,763 5,086,600 4,077,685
General and administrative 11,459,442 11,214,154 12,738,725
Impairment loss 93,050 412,999 2,826,918
Total operating expenses 24,485,235 22,979,882 25,503,517
Operating loss (25,841,309) (19,299,336) (26,337,828)
Other (income) expense      
Convertible note payable fair value adjustment 13,120,940
Investment loss (income), net 651,943 (82,798)
Interest (income) expense, net (56,628) 68,609 122,004
Loss on sale of equity method investment 4,008,357
Gain on divestiture of consumer segment (9,642,427)
Impairment on equity method investment 11,353,875
Equity method loss 734,143 503,625
Other, net (34,150) (708,265) (391)
Other expense 17,772,662 2,227,360 38,815
Net loss from continuing operations (43,613,971) (21,526,696) (26,376,643)
Loss from discontinued operations (2,525,933) (1,730,386)
Net loss (43,613,971) (24,052,629) (28,107,029)
Other comprehensive loss:      
Change in foreign currency translation adjustments (4,621) 1,573 (974)
Unrealized gain on marketable securities 864,165 610,129
Other comprehensive loss $ (43,618,592) $ (23,186,891) $ (27,497,874)
Loss per share - basic and diluted      
Continuing operations - basic $ (0.57) $ (0.36) $ (0.49)
Continuing operations - diluted (0.57) (0.36) (0.49)
Discontinued operations - basic (0.04) (0.03)
Discontinued operations - diluted (0.04) (0.03)
Loss per share - basic (0.57) (0.40) (0.52)
Loss per share - diluted $ (0.57) $ (0.40) $ (0.52)
Weighted average shares outstanding - basic 77,039,869 60,118,675 53,860,199
Weighted average shares outstanding - diluted 77,039,869 60,118,675 53,860,199

Source